The Indian Pharma Market (IPM) grew at 9.8 per cent for the month of January 2013 and was valued at Rs 5545 crores.
For the month of January 2013, amongst the top 10, Zydus clocked a growth of 22.1 per cent, Sun Pharma 21.9 per cent and Mankind 17.3 per cent. Five companies have crossed the growth of IPM for the month of January 2013. Without bonus Sun Pharma is ranked at second for the month and MAT for January 2013. Zydus has improved one rank over last month to be at number four on monthly basis.
Fourrts (India) Laboratories has entered the top 50 corporates. Amongst the top 50 corporates, the top three corporates in terms of growths are Bharat Serums has the highest growth at 35.6 per cent, USV at 24.9 per cent followed by Zydus at 22.1 per cent.
From a therapy perspective, 11 therapies have outgrown the IPM growth. The anti-infective market has a growth of 6.9 per cent whereas respiratory market is at 6.2 per cent growth. The anti-diabetic market grows at 15.6 per cent and cardiac at 14.5 per cent in chronic business.
About PharmaTrac
PharmaTrac is a the secondary sales data audit conducted by AIOCD Pharmasofttech AWACS, a pharmaceutical market research company formed by All Indian Origin Chemists & Distributors (AIOCD ) in a joint venture with Trikaal Mediinfotech.
AWACS in AIOCD AWACS stands for Advanced Working, Action & Correction System – reflecting the underlying philosophy behind AIOCD AWACS’ research tools to reduce time to information by 50 per cent or more and to significantly improve on accuracy of information. Accurate and faster information flows from the market will help clients grow topline and bottom-line.
Terminologies used
MAT – Moving Annual Total
MTH – Month
Val (Cr) – Value in Crores
MS per cent – Market Share in Percentage
GR per cent – Growth in percentage
For more information, visit http://www.aiocd.net